Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

28 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Rilpivirine-associated aggregation-induced emission enables cell-based nanoparticle tracking.
Mukadam IZ, Machhi J, Herskovitz J, Hasan M, Oleynikov MD, Blomberg WR, Svechkarev D, Mohs AM, Zhou Y, Dash P, McMillan J, Gorantla S, Garrison J, Gendelman HE, Kevadiya BD. Mukadam IZ, et al. Among authors: herskovitz j. Biomaterials. 2020 Feb;231:119669. doi: 10.1016/j.biomaterials.2019.119669. Epub 2019 Dec 7. Biomaterials. 2020. PMID: 31865227 Free PMC article.
Rod-shape theranostic nanoparticles facilitate antiretroviral drug biodistribution and activity in human immunodeficiency virus susceptible cells and tissues.
Kevadiya BD, Ottemann B, Mukadam IZ, Castellanos L, Sikora K, Hilaire JR, Machhi J, Herskovitz J, Soni D, Hasan M, Zhang W, Anandakumar S, Garrison J, McMillan J, Edagwa B, Mosley RL, Vachet RW, Gendelman HE. Kevadiya BD, et al. Among authors: herskovitz j. Theranostics. 2020 Jan 1;10(2):630-656. doi: 10.7150/thno.39847. eCollection 2020. Theranostics. 2020. PMID: 31903142 Free PMC article.
Creation of a long-acting rilpivirine prodrug nanoformulation.
Hilaire JR, Bade AN, Sillman B, Gautam N, Herskovitz J, Dyavar Shetty BL, Wojtkiewicz MS, Szlachetka A, Lamberty BG, Sravanam S, Fox HS, Alnouti Y, Dash PK, McMillan JM, Edagwa BJ, Gendelman HE. Hilaire JR, et al. Among authors: herskovitz j. J Control Release. 2019 Oct;311-312:201-211. doi: 10.1016/j.jconrel.2019.09.001. Epub 2019 Sep 3. J Control Release. 2019. PMID: 31491432 Free PMC article.
A long acting nanoformulated lamivudine ProTide.
Smith N, Bade AN, Soni D, Gautam N, Alnouti Y, Herskovitz J, Ibrahim IM, Wojtkiewicz MS, Dyavar Shetty BL, McMillan J, Gendelman HE, Edagwa B. Smith N, et al. Among authors: herskovitz j. Biomaterials. 2019 Dec;223:119476. doi: 10.1016/j.biomaterials.2019.119476. Epub 2019 Sep 5. Biomaterials. 2019. PMID: 31525692 Free PMC article.
CRISPR-Cas9 Mediated Exonic Disruption for HIV-1 Elimination.
Herskovitz J, Hasan M, Patel M, Blomberg WR, Cohen JD, Machhi J, Shahjin F, Mosley RL, McMillan J, Kevadiya BD, Gendelman HE. Herskovitz J, et al. EBioMedicine. 2021 Nov;73:103678. doi: 10.1016/j.ebiom.2021.103678. Epub 2021 Nov 10. EBioMedicine. 2021. PMID: 34774454 Free PMC article.
Pharmacotherapeutics of SARS-CoV-2 Infections.
Kevadiya BD, Machhi J, Herskovitz J, Oleynikov MD, Blomberg WR, Bajwa N, Soni D, Das S, Hasan M, Patel M, Senan AM, Gorantla S, McMillan J, Edagwa B, Eisenberg R, Gurumurthy CB, Reid SPM, Punyadeera C, Chang L, Gendelman HE. Kevadiya BD, et al. Among authors: herskovitz j. J Neuroimmune Pharmacol. 2021 Mar;16(1):12-37. doi: 10.1007/s11481-020-09968-x. Epub 2021 Jan 6. J Neuroimmune Pharmacol. 2021. PMID: 33403500 Free PMC article. Review.
28 results